Skip to main content
Site Search
Close Search

RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Digital PCR

Digital is the new absolute

Who we are

Learn about who we are and what we do to make improvements in life possible.

Join the QIAGEN team

Latest information on COVID-19

News, testing solutions and stories covering global efforts in the fight against COVID-19.

Our stories

Explore our digital magazine full of customer stories and videos on scientific breakthroughs and healthcare advances.

    Market Strategy

    Read our equity story, financial disclosures and how we create shareholder value.

      Latest News

      Read up on our latest press releases or peruse our various media archives.

      Contact Us

      Thank you for choosing QIAGEN. If you have questions about QIAGEN, our products or your order, this page should help you find the answers and contacts you need.

      Overview

      QIAGEN Deep Dive – QIAcuity digital PCR

      Home  >  Investor Relations  >  Events & Presentations  >  QIAGEN Deep Dive – QIAcuity digital PCR

      QIAGEN Deep Dive – QIAcuity digital PCR

      We are pleased to invite you to the next episode in a series of QIAGEN Deep Dives. This virtual event will focus on QIAcuity, our digital PCR solution.

      The session will provide insights into how QIAGEN is driving adoption of QIAcuity digital PCR, expanding into new application areas and building its position. You will hear directly from customers and QIAGEN experts and have the opportunity to engage in a live Q&A session.

      Downloads

      Register Join us on Monday, June 15, 2026, at 10:00 – 11:00 ET / 15:00 – 16:00 UK / 16:00 – 17:00 CET

      Speaker bios

      Download all

      See how QIAcuity digital PCR is used to address complex scientific challenges

      Driving precision in translational medicine

      Novel therapies require highly sensitive analytical methods to detect subtle biological changes with confidence. At Novartis, QIAcuity digital PCR enables precise quantification in AAV shedding studies, supporting regulatory requirements, reducing hands-on time and helping advance the development of precision medicines.

      Enabling scalable cell therapy manufacturing

      At Cellares, QIAcuity digital PCR supports vector copy number analysis and safety assays with precise, absolute quantification, helping detect low-level contamination. By enabling high- throughput workflows it strengthens quality control for scalable cell therapy manufacturing.

      Unlocking public health insights from wastewater

      Wastewater monitoring requires reliable methods to detect public health threats in complex environmental samples. Berliner Wasserbetriebeleverages QIAcuity digital PCR to enable accurate wastewater surveillance. Its sensitivity and robustness supports monitoring of water quality and public health.

      Identifying the genetics behind obesity using dPCR

      Obesity is one of the world’s most complex chronic diseases, with genetics playing a critical role in determining individual risk. Dr. Johanna Andersson-Assarsson’s research highlights how QIAcuity digital PCR enables precise copy number analysis, helping uncover genetic factors that could advance future obesity therapies and research.

        Learn More  

      A new climate for vector-borne diseases

      As climate change reshapes the spread of vector-borne diseases, researchers are turning to digital PCR to better understand emerging health risks. Dr. Melissa Nolan’s work highlights how QIAcuity digital PCR supports sensitive detection and helps advance public health research in a changing world.

        Learn More  

      A life after the first successful pediatric CAR T-cell Therapy

      After becoming the first child successfully treated with CAR-T cell therapy, Emily Whitehead’s journey became a milestone in cancer research. Her story showcases how advances in cell and gene therapy are helping transform scientific discovery into real-world patient benefit.

        Learn More